Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
J Shapiro, JJB Van Lanschot, MCCM Hulshof… - The lancet …, 2015 - thelancet.com
Background Initial results of the ChemoRadiotherapy for Oesophageal cancer followed by
Surgery Study (CROSS) comparing neoadjuvant chemoradiotherapy plus surgery versus …
Surgery Study (CROSS) comparing neoadjuvant chemoradiotherapy plus surgery versus …
[HTML][HTML] Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus
JBF Hulscher, JW van Sandick… - … England Journal of …, 2002 - Mass Medical Soc
Background Controversy exists about the best surgical treatment for esophageal carcinoma.
Methods We randomly assigned 220 patients with adenocarcinoma of the mid-to-distal …
Methods We randomly assigned 220 patients with adenocarcinoma of the mid-to-distal …
Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial
BM Eyck, JJB van Lanschot… - Journal of Clinical …, 2021 - ingentaconnect.com
PURPOSE Preoperative chemoradiotherapy according to the chemoradiotherapy for
esophageal cancer followed by surgery study (CROSS) has become a standard of care for …
esophageal cancer followed by surgery study (CROSS) has become a standard of care for …
The molecular biology of esophageal adenocarcinoma
LB Koppert, BPL Wijnhoven… - Journal of surgical …, 2005 - Wiley Online Library
Background Barrett's esophagus is an acquired metaplastic change that occurs in the distal
esophagus secondary to chronic gastroesophageal reflux. This premalignant condition …
esophagus secondary to chronic gastroesophageal reflux. This premalignant condition …
Preoperative risk assessment and prevention of complications in patients with esophageal cancer
BA Grotenhuis, BPL Wijnhoven, F Grüne… - Journal of surgical …, 2010 - Wiley Online Library
In this review the preoperative risk assessment and prevention of complications in patients
undergoing esophagectomy for cancer is discussed. Age, pulmonary and cardiovascular …
undergoing esophagectomy for cancer is discussed. Age, pulmonary and cardiovascular …
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis
BM Eyck, BD Onstenk, BJ Noordman, D Nieboer… - Annals of …, 2020 - journals.lww.com
Objective: The aim of this study was to perform a meta-analysis on the accuracy of
endoscopic biopsies, EUS, and 18F-FDG PET (-CT) for detecting residual disease after …
endoscopic biopsies, EUS, and 18F-FDG PET (-CT) for detecting residual disease after …
Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial
EB Deerenberg, JJ Harlaar, EW Steyerberg, HE Lont… - The Lancet, 2015 - thelancet.com
Background Incisional hernia is a frequent complication of midline laparotomy and is
associated with high morbidity, decreased quality of life, and high costs. We aimed to …
associated with high morbidity, decreased quality of life, and high costs. We aimed to …
The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials
K Slankamenac, N Nederlof, P Pessaux… - Annals of …, 2014 - journals.lww.com
Objective: To test whether the newly developed comprehensive complication index (CCI) is
more sensitive than traditional endpoints for detecting between-group differences in …
more sensitive than traditional endpoints for detecting between-group differences in …
Treatment of locally advanced esophageal carcinoma: ASCO guideline
MA Shah, EB Kennedy, DV Catenacci… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To develop an evidence-based clinical practice guideline to assist in clinical
decision making for patients with locally advanced esophageal cancer. METHODS ASCO …
decision making for patients with locally advanced esophageal cancer. METHODS ASCO …
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
BJ Noordman, MCW Spaander, R Valkema… - The Lancet …, 2018 - thelancet.com
Background After neoadjuvant chemoradiotherapy for oesophageal cancer, roughly half of
the patients with squamous cell carcinoma and a quarter of those with adenocarcinoma …
the patients with squamous cell carcinoma and a quarter of those with adenocarcinoma …